Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach

• Friedrich Wittenbecher,
• Friedrich Wittenbecher,
• Stella Lesch,
• Stefan Kolling,
• Igor-Wolfgang Blau,
• Lam Vuong,
• Franziska Borchert,
• Kamran Movasshagi,
• Carola Tietze-Bürger,
• Olaf Penack,
• Olaf Penack,
• Johann Ahn,
• Lars Bullinger,
• Lars Bullinger,
• Lars Bullinger,
• Marco Frentsch,
• Marco Frentsch,
• Il-Kang Na,
• Il-Kang Na,
• Il-Kang Na,
• Il-Kang Na

Affiliations

Friedrich Wittenbecher

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Friedrich Wittenbecher

Berlin Institute of Health, Charité – Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany

Stella Lesch

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Stefan Kolling

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Igor-Wolfgang Blau

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Lam Vuong

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Franziska Borchert

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Kamran Movasshagi

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Carola Tietze-Bürger

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Olaf Penack

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Olaf Penack

Berlin Institute of Health, Charité – Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany

Johann Ahn

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Lars Bullinger

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Lars Bullinger

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany

Lars Bullinger

Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany

Marco Frentsch

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Marco Frentsch

Berlin Institute of Health, Charité – Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany

Il-Kang Na

Department of Hematology, Oncology, and Tumor Immunology, Charite´ – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Il-Kang Na

Berlin Institute of Health, Charité – Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany

Il-Kang Na

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany

Il-Kang Na

Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany